Peculiarities of multidrug-resistant tuberculosis on the background of idiopathic pulmonary fibrosis (a clinical case report)
DOI:
https://doi.org/10.14739/2310-1210.2019.4.173363Keywords:
idiopathic pulmonary fibrosis, multi-drug resistant tuberculosisAbstract
Objective – familiarization of practitioners with the peculiarities of pulmonary multi-drug resistant tuberculosis (MDRT) in a patient with idiopathic pulmonary fibrosis (IPF) resulted from a long exposure to environmental factors at the workplace.
Materials and methods. The article deals with a clinical case of own observation of pulmonary MDRT development in a patient with IPF. The patient was hospitalized in the Pulmonary Tuberculosis Department No 3 (Department of Resistant Tuberculosis) of the Clinical Site of Phthisiology and Pulmonology Department of Zaporizhizhia State Medical Univercity in the CI “Zaporizhzhia Regional Tuberculosis Clinical Dispensary”.
The results of our own observations. Patient: male, 41 years, no medical history of tuberculosis. His work was associated with a harmful environmental factor within 7 years: dust in the workplace (refueling and repair of powder-type fire extinguishers). After 3 weeks of inpatient treatment, the patient died. The presented clinical case demonstrates the complexity of a life-time IPF diagnosis, which progression provoked the development of an equally serious disease, such as multi-resistant disseminated pulmonary tuberculosis and the prescription of antimycobacterial therapy. The cause of death was a progressive pulmonary fibrosis, and as a result, a progressively worsening pulmonary heart disease.
Conclusions. Practitioners should be especially vigilant and attentive while dealing with a patient having a history of harmful environmental factors exposure that may cause IPF development. It must be borne in mind that IPF may be asymptomatic for a long time resulting in increased risk for developing tuberculosis. This case confirms the literature data that the development of pulmonary MDRT in patients with untreated IPF leads to a rapid fatal outcome in the vast majority of cases (in this case it was 3 weeks).
References
Gavrisyuk, V. K. (2011). Fibroziruyushhie al'veolity [Fibrosing alveolitis]. Klinichna imunolohiia. Alerholohiia. Infektolohiia, 5–12. [in Ukrainian].
Kilessa, V. V. (2009). Idiopaticheskij fibroziruyushhij al'veolit [Idiopathic fibrosing alveolitis]. Tavricheskij mediko-biologicheskij vestnik, 12, 1(45), 173–176. [in Russian].
Travis, W. D., Costabe, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G. et al. (2013). An official American Thoracic Society / European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med, 188(6), 733–748. doi: 10.1164/rccm.201308-1483ST
Averyanov, A. V., & Lesnyak, V. N. (2016). Ot idiopaticheskogo fibroziruyushhego al'veolita k idiopaticheskomu legochnomu fibrozu (Chast' II) [From idiopathic fibrosing alveolitis to idiopatic lungs fibrosis]. Klinicheskaya praktika, 4(28), 58–64. [in Russian].
Avdeev, S. N. (2015). Idiopaticheskij legochnyj fibroz [Idiopathic pulmonary fibrosis]. Pul'monologiya, 25(5), 600–612. doi: 10.18093/0869-189-2015-25-5-600-612 [in Russian].
Il'kovich, M. M., Novikova, L. N., & Speranskaya, A. A. (2009). Idiopaticheskij fibroziruyushhij al'veolit: sovremennye predstavleniya [Idiopathic pulmonary fibrosis: the current view]. Consilium Medicum, 11(11), 24–29. [in Russian].
Ryu, J. H., Moua, T., Daniels, C. E., Hartman, T. E., Yi, E., Utz, J. P., & Limper, A. H. (2014). Idiopathic pulmonary fibrosis: evolving concepts. Mayo. Clin. Proc., 89(8), 1130–1142. doi: 10.1016/j.mayocp.2014.03.016
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., et al. (2011). An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis; evidence based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med, 183(6), 788–824. doi: 10.1164/rccm.2009-040GL
Novikova, L., Ilkovich, Y. Speranskaya, A. (2015). Tuberculosis in patients with idiopathic pulmonary fibrosis. European Respiratory Journal, 46(59). doi: 10.1183/13993003.congress-2015.PA2046
(2014). Ukraina. MOZ. Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy doroslym. Tuberkuloz [Unified clinical protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care for adults "Tuberculosis"]. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)